MedTrace Logo

Effect of High Flow Nasal Cannula Versus Nasal Continuous Positive Airway Pressure

NCT05849116 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-05-08

No results posted yet for this study

Summary

Respiratory distress syndrome (RDS) in preterm babies is caused by a deficiency of lung surfactant. The risk of RDS increases with decreasing gestational age, and is almost inevitable in babies born at less than 28 weeks gestation. Without surfactant the lungs become stiff and the alveoli collapse at end-expiration, and untreated RDS is a major cause of morbidity and mortality in preterm infants

Conditions

  • Respiratory Distress Syndrome

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Gafar Ibrahim, Prof · Assiut University

  • Safwat Moahmed, Assist prof · Assiut University

Eligibility

Min Age
30 Weeks
Max Age
37 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-06-01
Completion
2024-08-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05849116 on ClinicalTrials.gov